Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib.

J Thorac Dis · 2020 · PMC7656377 · PMID 33209408

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Pretreatment PNI showed a trend towards being a factor for PFS but did not reach the level of statistical significance (HR 1.90; 95% CI, 0.98–3.68, P=0.05).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.